JNK plays a key role in tau hyperphosphorylation in alzheimer's disease models

Journal of Alzheimer's Disease

Volumn 26, Issue 2, 2011, Pages 315-329

  Ploia, Cristina ^a   Antoniou, Xanthi ^a   Sclip, Alessandra ^a   Grande, Valentina ^a,e   Cardinetti, Daniele ^a   Colombo, Alessio ^a,f   Canu, Nadia ^b,c   Benussi, Luisa ^d   Ghidoni, Roberta ^d   Forloni, Gianluigi ^a   Borsello, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease; D JNKI 1; JNK mitogen activated protein kinases; phosphorylation; tau protein

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME INHIBITION; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT;

EID: 80052811773     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110320     Document Type: Article

References (67)

1. Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142-149. (Pubitemid 46386399)
2. Borsello T, Forloni G (2007) JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des 13, 1875-1886. (Pubitemid 47010160)
3. Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev 123, 39-46. (Pubitemid 32972257)
4. Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinaseindegenerating neurons in Alzheimer's disease. J Neurochem 76, 435-441. (Pubitemid 32097021)
5. Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa CF, Ono S, Okazawa H (2000) JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res Mol Brain Res 85, 221-233. (Pubitemid 32056254)
6. Sato S, Tatebayashi Y, Akagi T, Chui DH, Murayama M, Miyasaka T, Planel E, Tanemura K, Sun X, Hashikawa T, Yoshioka K, Ishiguro K, Takashima A (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3 beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J Biol Chem 277, 42060-42065. (Pubitemid 35257520)
7. Thakur A, Wang X, Siedlak SL, Perry G, Smith MA, Zhu X (2007) c-Jun phosphorylation in Alzheimer disease. J Neu-rosci Res 85, 1668-1673. (Pubitemid 46849614)
8. Zhu X, Ogawa O, Wang Y, Perry G, Smith MA (2003) JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease. J Neurochem 85, 87-93. (Pubitemid 36389698)
9. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, Shirasaki Y, Greenberg ME (2001) Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 21, 7551-7560. (Pubitemid 32904954)
10. Minogue AM, Schmid AW, Fogarty MP, Moore AC, Campbell VA, Herron CE, Lynch MA (2003) Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1 beta? J Biol Chem 278, 27971-27980. (Pubitemid 36899992)
11. 2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein. J Neurosci 25, 3741-3751. (Pubitemid 40570407)
12. Vingtdeux V, Hamdane M, Gompel M, Begard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, Buee L, Delacourte A, Sergeant N (2005) Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol Dis 20, 625-637. (Pubitemid 41476288)
13. Colombo A, Repici M, Pesaresi M, Santambrogio S, Forloni G, Borsello T (2007) The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability. Cell Death Differ 14, 1845-1848. (Pubitemid 47423652)
14. Colombo A, Bastone A, Ploia C, Sclip A, Salmona M, Forloni G, Borsello T (2009) JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Neurobiol Dis 33, 518-525.
15. Ferrer I, Blanco R, Carmona M, Puig B (2001) Phospho-rylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J Neural Transm 108, 1397-1415. (Pubitemid 34020445)
16. Bellucci A, Rosi MC, Grossi C, Fiorentini A, Luccarini I, Casamenti F (2007) Abnormal processing of tau in the brain of aged TgCRND8 mice. Neurobiol Dis 27, 328-338. (Pubitemid 47333192)
17. Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29, 9078-9089.
18. Vogel J, Anand VS, Ludwig B, Nawoschik S, Dunlop J, Braithwaite SP (2009) The JNK pathway amplifies and drives subcellular changesintauphosphorylation. Neuropharmacol-ogy 57, 539-550.
19. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
20. Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS (2003) A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets 4, 97-112. (Pubitemid 36553583)
21. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102, 6990-6995. (Pubitemid 40675429)
22. Sereno L, Coma M, Rodriguez M, Sanchez-Ferrer P, Sanchez MB, Gich I, Agullo JM, Perez M, Avila J, Guardia-Laguarta C, Clarimon J, Lleo A, Gomez-Isla T (2009) A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis 35, 359-367.
23. Su JH, Cummings BJ, Cotman CW (1994) Early phosphory-lation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 5, 2358-2362. (Pubitemid 24374873)
24. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103, 26-35. (Pubitemid 36075309)
25. Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R (2007) Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. J Alzheimers Dis 12, 365-375.
26. Yoshida H, Hastie CJ, McLauchlan H, Cohen P, Goedert M (2004) Phosphorylationof microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 90, 352-358. (Pubitemid 38938221)
27. Reynolds CH, Utton MA, Gibb GM, Yates A, Anderton BH (1997) Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J Neurochem 68, 1736-1744. (Pubitemid 27133085)
28. Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L (2010) Phospho-rylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Neurobiol Dis 37, 294-306.
29. Malaplate-Armand C, Desbene C, Pillot T, Olivier JL (2009) [Biomarkers for early diagnosis of Alzheimer's disease: current update and future directions]. Rev Neurol (Paris) 165, 511-520.
30. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excito-toxicity and cerebral ischemia. Nat Med 9, 1180-1186. (Pubitemid 37173703)
31. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50, 77-82. (Pubitemid 32047984)
32. Repici M, Mare L, Colombo A, Ploia C, Sclip A, Bonny C, Nicod P, Salmona M, Borsello T (2009) c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons. Neuroscience 159, 94-103.
33. Antoniou X, Sclip A, Ploia C, Colombo A, Moroy G, Borsello T (2009) JNK contributes to Hif-1 alpha regulation in hypoxic neurons. Molecules 15, 114-127.
34. Lesuisse C, Martin LJ (2002) Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab 22, 935-950. (Pubitemid 34831600)
35. Li JH, Wang YH, Wolfe BB, Krueger KE, Corsi L, Stocca G, Vicini S (1998) Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons. Eur J Neurosci 10, 1704-1715. (Pubitemid 28327317)
36. Benussi L, Govoni S, Gasparini L, Binetti G, Trabucchi M, Bianchetti A, Racchi M (1998) Specific role for protein kinase C alpha in the constitutive and regulated secretion of amyloid precursor proteininhuman skinfibroblasts. Neurosci Lett240, 97-101. (Pubitemid 28078952)
37. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
38. Zhao R, Zhang S, Xu Z, Ju L, Lu D, Yao G (2007) Studying gene expression profile of rat neuron exposed to 1800 MHz radiofrequency electromagnetic fields with cDNA microas-say. Toxicology 235, 167-175. (Pubitemid 46734547)
39. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562-21570. (Pubitemid 37413154)
40. Repici M, Centeno C, Tomasi S, Forloni G, Bonny C, Vercelli A, Borsello T (2007) Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation. Neuroscience 150, 40-49. (Pubitemid 350198685)
41. Bellucci A, Luccarini I, Scali C, Prosperi C, Giovannini MG, Pepeu G, Casamenti F (2006) Cholinergic dysfunction, neu-ronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis 23, 260-272. (Pubitemid 44080837)
42. Cardozo AK, Buchillier V, Mathieu M, Chen J, Ortis F, Ladriere L, Allaman-Pillet N, Poirot O, Kellenberger S, Beckmann JS, Eizirik DL, Bonny C, Maurer F (2007) Cell-permeable peptides induce dose-and length-dependent cytotoxic effects. Biochim Biophys Acta 1768, 2222-2234. (Pubitemid 47379621)
43. Rossi G, Dalpra L, Crosti F, Lissoni S, Sciacca FL, Catania M, Di Fede G, Mangieri M, Giaccone G, Croci D, Tagliavini F (2008) A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle 7, 1788-1794. (Pubitemid 351988745)
44. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau proteinphosphorylatedatboth serine 202 and threonine 205. Neurosci Lett 189, 167-169.
45. Kimura T, Ono T, Takamatsu J, Yamamoto H, Ikegami K, Kondo A, Hasegawa M, Ihara Y, Miyamoto E, Miyakawa T (1996) Sequential changes of tau-site-specific phosphoryla-tion during developmentofpaired helical filaments.Dementia 7, 177-181.
46. Lauckner J, Frey P, Geula C (2003) Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 24, 767-776. (Pubitemid 37303986)
47. Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A (2003) Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Acta Neuropathol 105, 89-97. (Pubitemid 36798793)
48. Bussiere T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin ML, Perl DP, Buee L, Delacourte A (1999) Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neu-ropathol 97, 221-230. (Pubitemid 29137270)
49. Johnson GV, Stoothoff WH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117, 5721-5729. (Pubitemid 40123939)
50. Ashe KH (2007) A tale about tau. N Engl JMed 357, 933-935.
51. Lee VM, Trojanowski JQ (2001) Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease. Neurology 56, S26-S30. (Pubitemid 32539644)
52. Buee-Scherrer V, Goedert M (2002) Phosphorylation of microtubule- associated protein tau by stress-activated protein kinases in intact cells. FEBS Lett 515, 151-154. (Pubitemid 34273915)
53. Gallo JM, Hanger DP, Twist EC, Kosik KS, Anderton BH (1992) Expression and phosphorylation of a three-repeat iso-form of tau in transfected non-neuronal cells. Biochem J 286 (Pt 2), 399-404.
54. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E (1992) Glyco-gen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314, 315-321. (Pubitemid 23005680)
55. Kobayashi S, Ishiguro K, Omori A, Takamatsu M, Arioka M, Imahori K, Uchida T (1993) A cdc2-related kinase PSSALRE/cdk5is homologous with the 30kDa subunitof tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett 335, 171-175. (Pubitemid 23350401)
56. Paudel HK, Lew J, Ali Z, Wang JH (1993) Brain proline-direc-ted protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem 268, 23512-23518. (Pubitemid 23328079)
57. Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH (1997) Reactivating kinase/p38 phosphorylates tau protein in vitro. J Neurochem 69, 191-198. (Pubitemid 27274172)
58. Aplin AE, Gibb GM, Jacobsen JS, Gallo JM, Anderton BH (1996) In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3 beta. J Neurochem 67, 699-707. (Pubitemid 26255667)
59. Iijima K, Ando K, Takeda S, Satoh Y, Seki T, Itohara S, Greengard P, Kirino Y, Nairn AC, Suzuki T (2000) Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 75, 1085-1091. (Pubitemid 30660497)
60. Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau KF, McLoughlin DM, Miller CC (2001) Phosphorylation of thr (668) inthe cytoplasmic domainofthe Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1 b (Jun N-terminal kinase-3). J Neurochem 76, 316-320. (Pubitemid 32044394)
61. Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, Neve R, Ahlijanian MK, Tsai LH (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163, 83-95. (Pubitemid 37271436)
62. Mohit AA, Martin JH, Miller CA (1995) p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 14, 67-78.
63. Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illen-berger S, Godemann R, Mandelkow E (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation. Eur J Biochem 252, 542-552. (Pubitemid 28156880)
64. Shea TB, Cressman CM (1999) The orderofexposureoftau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes. Cell Mol Neurobiol 19, 223-233. (Pubitemid 29096111)
65. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. (Pubitemid 37494698)
66. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001) Decreased nuclear beta-catenin, tau hyperphos-phorylation and neurodegenerationinGSK-3 beta conditional transgenic mice. Embo J 20, 27-39. (Pubitemid 32099099)
67. Hanger DP, Anderton BH, Noble W (2009) Tau phosphoryla-tion: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15, 112-119.